We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+12.73%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
–
AUM
$2.01B
AUM Growth
+$202M
Cap. Flow
+$14.9M
Cap. Flow %
0.74%
Top 10 Hldgs %
34.18%
Holding
238
New
11
Increased
56
Reduced
56
Closed
10

Top Buys

Rank Stock Value
1
TDC icon
Teradata
TDC
+$19M
2
UNH icon
UnitedHealth
UNH
+$15.2M
3
INTU icon
Intuit
INTU
+$11M
4
TSM icon
TSMC
TSM
+$9.83M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$9.27M

Top Sells

Rank Stock Value
1
ALBO
Albireo Pharma Inc
ALBO
+$29.4M
2
SIVB
SVB Financial Group
SIVB
+$23.7M
3
EW icon
Edwards Lifesciences
EW
+$20.7M
4
CCSI icon
Consensus Cloud Solutions
CCSI
+$13.6M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 27.58%
2 Healthcare 21.34%
3 Financials 14.12%
4 Communication Services 11.1%
5 Consumer Discretionary 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
76
Merck
MRK
$322B
$2.27M 0.11%
21,322
+15
+0.1% +$1.62K
ADBE icon
77
Adobe
ADBE
$99.5B
$2.26M 0.11%
5,862
+1,216
+26% +$432K
ORLY icon
78
O'Reilly Automotive
ORLY
$72.9B
$2.19M 0.11%
38,715
– –
CSCO icon
79
Cisco
CSCO
$457B
$1.93M 0.1%
36,848
+281
+0.8% +$13.7K
ADP icon
80
Automatic Data Processing
ADP
$106B
$1.72M 0.09%
7,707
-120
-2% -$27.1K
GE icon
81
GE Aerospace
GE
$374B
$1.7M 0.08%
22,270
-6,220
-22% -$416K
ORCL icon
82
Oracle
ORCL
$374B
$1.69M 0.08%
18,190
– –
AXP icon
83
American Express
AXP
$227B
$1.62M 0.08%
9,849
– –
NKE icon
84
Nike
NKE
$61.9B
$1.6M 0.08%
13,070
+495
+4% +$60.9K
YUM icon
85
Yum! Brands
YUM
$41.8B
$1.6M 0.08%
12,086
– –
CVX icon
86
Chevron
CVX
$392B
$1.59M 0.08%
9,720
+26
+0.3% +$4.36K
GWW icon
87
W.W. Grainger
GWW
$65.3B
$1.51M 0.08%
2,188
– –
RTX icon
88
RTX Corp
RTX
$290B
$1.51M 0.08%
15,383
– –
ECL icon
89
Ecolab
ECL
$78.1B
$1.49M 0.07%
8,972
– –
VZ icon
90
Verizon
VZ
$195B
$1.48M 0.07%
38,155
-3,538
-8% -$140K
INTC icon
91
Intel
INTC
$455B
$1.47M 0.07%
45,142
-210
-0.5% -$5.95K
SBUX icon
92
Starbucks
SBUX
$120B
$1.45M 0.07%
13,891
-647
-4% -$67.3K
BRK.A icon
93
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.4M 0.07%
3
– –
UNP icon
94
Union Pacific
UNP
$174B
$1.36M 0.07%
6,738
– –
WMT icon
95
Walmart Inc
WMT
$885B
$1.3M 0.06%
26,412
-210
-0.8% -$9.97K
IWM icon
96
iShares Russell 2000 ETF
IWM
$79.8B
$1.23M 0.06%
6,906
-92
-1% -$16.9K
VGK icon
97
Vanguard FTSE Europe ETF
VGK
$30.7B
$1.22M 0.06%
20,000
– –
BP icon
98
BP
BP
$116B
$1.17M 0.06%
30,839
– –
DUK icon
99
Duke Energy
DUK
$97.8B
$1.15M 0.06%
11,883
+329
+3% +$32.5K
IBM icon
100
IBM
IBM
$211B
$1.1M 0.05%
8,402
-13
-0.2% -$1.74K
2 3
4
5 6

Similar funds

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Chicago Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Chicago Capital held 238 positions worth $2.01B, up 11% from $1.81B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Chicago Capital's Q1 2023 filing shows 11 new, 56 increased, 56 reduced and 10 closed positions. Its largest new stake was Factset: 1,141 shares worth $474K. The largest sale was Albireo Pharma Inc, an estimated $29.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Chicago Capital's largest Q1 2023 buy was Factset: 1,141 shares worth $474K.
  • Chicago Capital added most to Teradata in Q1 2023, an estimated $19M increase.
  • Chicago Capital's biggest Q1 2023 reduction was Edwards Lifesciences, cutting an estimated $20.7M.
  • Chicago Capital fully exited Albireo Pharma Inc in Q1 2023, selling an estimated $29.4M.
  • Chicago Capital's ten largest holdings make up 34% of its $2.01B portfolio in Q1 2023.
  • Chicago Capital opened 11 new positions and closed 10 in Q1 2023.
  • Chicago Capital's portfolio value rose 11% quarter-over-quarter to $2.01B.

Based on Chicago Capital's 13F filing for Q1 2023, filed 18 Apr 2023.